Abstract
While the clinical characteristics and treatment outcomes of Enterococcus faecalis and E. faecium bacteremia are well known, those of E. durans bacteremia are still largely unclear. We retrospectively identified 80 adult E. durans bacteremia cases treated at our 2700-bed tertiary care hospital between January 1997 and December 2016. We compared the clinical characteristics and treatment outcomes of the adult patients with E. durans bacteremia (case group) with those of E. faecalis and E. faecium bacteremia cases (two control groups). The case and control groups were matched for sex, age, and date of onset of bacteremia. E. durans was responsible for 1.2% of all enterococcal bacteremia cases at our hospital. Of 80 cases, 39 (48.8%) had biliary tract infection and 18 (22.5%) had urinary tract infection. Community-onset bacteremia was more frequent in the case group than in the control groups (56.2% vs. 35.0% vs. 21.2%, p < 0.01). Infective endocarditis tended to be more common in the E. durans group (7.5% vs. 1.2% vs. 1.2%, p = 0.05). The majority of E. durans isolates were susceptible to penicillin (66/76, 86.8%), ampicillin (67/76, 88.2%), and vancomycin (75/76, 98.7%). The case group had significantly lower all-cause mortality (20.0% vs. 31.2% vs. 42.5%, p < 0.01) and bacteremia-related mortality (2.5% vs. 16.2% vs. 18.8%, p < 0.01) than the control groups. E. durans bacteremia mainly originates from the biliary or urinary tract and is associated with a lower risk of mortality.
Similar content being viewed by others
References
Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29(11):996–1011. https://doi.org/10.1086/591861
Brown DF, Hope R, Livermore DM, Brick G, Broughton K, George RC, Reynolds R (2008) Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 62(Suppl 2):ii75–ii85. https://doi.org/10.1093/jac/dkn354
Sherman JM, Wing HU (1937) Streptococcus durans n. sp. J Dairy Sci 20(3):165–167
Abe Y, Nakamura K, Yamada M, Yamamoto Y (2006) Encephalomalacia with Enterococcus durans infection in the brain stem and cerebral hemisphere in chicks in Japan. Avian Dis 50(1):139–141. https://doi.org/10.1637/7419-080805r.1
Cheon DS, Chae C (1996) Outbreak of diarrhea associated with Enterococcus durans in piglets. J Vet Diagn Investig 8(1):123–124. https://doi.org/10.1177/104063879600800123
Collins M, Jones D, Farrow J, Kilpper-Balz R, Schleifer K (1984) Enterococcus avium nom. rev., comb. nov.; E. casseliflavus nom. rev., comb. nov.; E. durans nom. rev., comb. nov.; E. gallinarum comb. nov.; and E. malodoratus sp. nov. Int J Syst Evol Microbiol 34(2):220–223
Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 28(3):435–437
Tan CK, Lai CC, Wang JY, Lin SH, Liao CH, Huang YT, Wang CY, Lin HI, Hsueh PR (2010) Bacteremia caused by non-faecalis and non-faecium enterococcus species at a medical center in Taiwan, 2000 to 2008. J Infect 61(1):34–43. https://doi.org/10.1016/j.jinf.2010.04.007
Watanabe T, Shimohashi H, Kawai Y, Mutai M (1981) Studies on streptococci. I. Distribution of fecal streptococci in man. Microbiol Immunol 25(3):257–269
Abamecha A, Wondafrash B, Abdissa A (2015) Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia. BMC Res Notes 8:213. https://doi.org/10.1186/s13104-015-1200-2
Gaspar F, Teixeira N, Rigottier-Gois L, Marujo P, Nielsen-LeRoux C, Crespo MT, Lopes Mde F, Serror P (2009) Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE. Microbiology 155 (Pt 11:3564–3571. https://doi.org/10.1099/mic.0.030775-0
Stepanovic S, Jovanovic M, Lavadinovic L, Stosovic B, Pelemis M (2004) Enterococcus durans endocarditis in a patient with transposition of the great vessels. J Med Microbiol 53(Pt 3):259–261. https://doi.org/10.1099/jmm.0.05382-0
Vijayakrishnan R, Rapose A (2012) Fatal Enterococcus durans aortic valve endocarditis: a case report and review of the literature. BMJ Case Rep 2012. doi:https://doi.org/10.1136/bcr-02-2012-5855
Kenzaka T, Takamura N, Kumabe A, Takeda K (2013) A case of subacute infective endocarditis and blood access infection caused by Enterococcus durans. BMC Infect Dis 13:594. https://doi.org/10.1186/1471-2334-13-594
Fallavollita L, Di Gioacchino L, Balestrini F (2016) Bioprosthetic aortic valve endocarditis in association with Enterococcus durans. Tex Heart Inst J 43(2):165–167. https://doi.org/10.14503/thij-14-4980
Zala A, Collins N (2016) Enterococcus durans prosthetic valve endocarditis: a previously unreported clinical entity. Heart Lung Circ 25(10):e133–e136. https://doi.org/10.1016/j.hlc.2016.01.010
Manero A, Blanch AR (1999) Identification of Enterococcus spp. with a biochemical key. Appl Environ Microbiol 65(10):4425–4430
CLSI (2016) Performance standards for antimicrobial susceptibility testing; 26 ed. CLSI supplement M100S. CLSI, Wayne, PA
Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797
Mc CW, Jackson G (1962) Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 110(6):847–855. https://doi.org/10.1001/archinte.1962.03620240029006
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). Jama 315(8):801–810. https://doi.org/10.1001/jama.2016.0287
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309–317. https://doi.org/10.1086/421946
Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G (2011) Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study. Diagn Microbiol Infect Dis 69(4):363–369. https://doi.org/10.1016/j.diagmicrobio.2010.10.016
Frickmann H, Koller K, Veil I, Weise M, Ludyga A, Schwarz NG, Warnke P, Podbielski A (2017) On the role of enterococci in the bloodstream: results of a single-center, retrospective, observational study at a German university hospital. Eur J Microbiol Immunol (Bp) 7(4):284–295. https://doi.org/10.1556/1886.2017.00030
Coombs GW, Pearson JC, Daley DA, Le T, Robinson OJ, Gottlieb T, Howden BP, Johnson PD, Bennett CM, Stinear TP, Turnidge JD (2014) Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol 52(3):897–905. https://doi.org/10.1128/jcm.03286-13
Choi SH, Lee SO, Kim TH, Chung JW, Choo EJ, Kwak YG, Kim MN, Kim YS, Woo JH, Ryu J, Kim NJ (2004) Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases. Clin Infect Dis 38(1):53–61. https://doi.org/10.1086/380452
Na S, Park HJ, Park KH, Cho OH, Chong YP, Kim SH, Lee SO, Sung H, Kim MN, Jeong JY, Kim YS, Woo JH, Choi SH (2012) Enterococcus avium bacteremia: a 12-year clinical experience with 53 patients. Eur J Clin Microbiol Infect Dis 31(3):303–310. https://doi.org/10.1007/s10096-011-1311-1
Kau AL, Martin SM, Lyon W, Hayes E, Caparon MG, Hultgren SJ (2005) Enterococcus faecalis tropism for the kidneys in the urinary tract of C57BL/6J mice. Infect Immun 73(4):2461–2468. https://doi.org/10.1128/iai.73.4.2461-2468.2005
Singh KV, Nallapareddy SR, Murray BE (2007) Importance of the ebp (endocarditis- and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J Infect Dis 195(11):1671–1677. https://doi.org/10.1086/517524
Di Rosa R, Creti R, Venditti M, D’Amelio R, Arciola CR, Montanaro L, Baldassarri L (2006) Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol Lett 256(1):145–150. https://doi.org/10.1111/j.1574-6968.2006.00112.x
Mohamed JA, Huang DB (2007) Biofilm formation by enterococci. J Med Microbiol 56(Pt 12):1581–1588. https://doi.org/10.1099/jmm.0.47331-0
Popovic N, Dinic M, Tolinacki M, Mihajlovic S, Terzic-Vidojevic A, Bojic S, Djokic J, Golic N, Veljovic K (2018) New insight into biofilm formation ability, the presence of virulence genes and probiotic potential of Enterococcus sp. dairy isolates. Front Microbiol 9:78. https://doi.org/10.3389/fmicb.2018.00078
Chow JW, Thal LA, Perri MB, Vazquez JA, Donabedian SM, Clewell DB, Zervos MJ (1993) Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother 37(11):2474–2477
Shankar V, Baghdayan AS, Huycke MM, Lindahl G, Gilmore MS (1999) Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 67(1):193–200
DiazGranados CA, Zimmer SM, Klein M, Jernigan JA (2005) Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41(3):327–333. https://doi.org/10.1086/430909
Salgado CD, Farr BM (2003) Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 24(9):690–698. https://doi.org/10.1086/502271
Prematunge C, MacDougall C, Johnstone J, Adomako K, Lam F, Robertson J, Garber G (2016) VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37(1):26–35. https://doi.org/10.1017/ice.2015.228
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the Asan Medical Center Institutional Review Board.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOC 46 kb)
Rights and permissions
About this article
Cite this article
Ryu, BH., Hong, J., Jung, J. et al. Clinical characteristics and treatment outcomes of Enterococcus durans bacteremia: a 20-year experience in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 38, 1743–1751 (2019). https://doi.org/10.1007/s10096-019-03605-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-019-03605-z